Aurora Cannabis Inc. (TSE:ACB – Get Free Report) hit a new 52-week low during trading on Tuesday . The stock traded as low as C$3.75 and last traded at C$3.84, with a volume of 284792 shares. The stock had previously closed at C$3.87.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on the company. TD cut their price objective on Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating on the stock in a report on Friday, June 12th. Canaccord Genuity Group reduced their price objective on shares of Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating on the stock in a research note on Tuesday, June 30th. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Aurora Cannabis has a consensus rating of “Buy” and a consensus target price of C$7.17.
Aurora Cannabis Trading Down 2.1%
Aurora Cannabis (TSE:ACB – Get Free Report) last issued its quarterly earnings data on Thursday, June 11th. The company reported C($0.99) EPS for the quarter. The business had revenue of C$38.01 million during the quarter. Aurora Cannabis had a negative return on equity of 7.25% and a negative net margin of 12.13%. On average, research analysts expect that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.
Aurora Cannabis Company Profile
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
See Also
- Five stocks we like better than Aurora Cannabis
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
- Abivax: Wall Street Catches Up to the Data
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
